112 related articles for article (PubMed ID: 18561374)
1. Advances in the biology and therapy of acute myelogenous leukemia. Selection of keynote addresses from the Acute Leukemia Forum 2007. March 23, 2007. San Francisco, California, USA.
Best Pract Res Clin Haematol; 2008 Mar; 21(1):1-98. PubMed ID: 18561374
[No Abstract] [Full Text] [Related]
2. Acute Leukemia Forum '98. Advances and controversies in the biology and treatment of acute myelogenous leukemia and myelodysplasia. Symposium proceedings. San Francisco, California, USA. March 6, 1998.
Leukemia; 1998 Sep; 12 Suppl 1():S1-56. PubMed ID: 9841272
[No Abstract] [Full Text] [Related]
3. Selection of keynote addresses presented at the Acute Leukemia Forum 2006. March 31, 2006. San Francisco, California, USA.
Best Pract Res Clin Haematol; 2007 Mar; 20(1):1-118. PubMed ID: 17336248
[No Abstract] [Full Text] [Related]
4. Acute Leukemia Forum '99: Advances and Controversies in the Therapy of Acute Myeloid Leukemia. San Francisco, California, USA. 16 April 1999. Proceedings.
Leukemia; 2000 Mar; 14(3):466-517. PubMed ID: 10755889
[No Abstract] [Full Text] [Related]
5. Acute Leukemia Forum '95: Advances and Controversies in Induction Therapy and Treatment of Older Adults with AML. Symposium proceedings. San Francisco, California, USA, November 10, 1995.
Leukemia; 1996 Apr; 10 Suppl 1():S1-48. PubMed ID: 8618460
[No Abstract] [Full Text] [Related]
6. Leukemia burden and outcome of allogeneic transplant in acute myelogenous leukemia.
Kamble RT; Hjortsvang E; Selby GB
Biol Blood Marrow Transplant; 2006 Jun; 12(6):691-2. PubMed ID: 16737944
[No Abstract] [Full Text] [Related]
7. Therapy for acute myelogenous leukemia revisited: moving away from a one-size-fits-all approach.
Reikvam H; Hemsing AL; Smith C
Expert Rev Anticancer Ther; 2021 Jan; 21(1):5-8. PubMed ID: 33059507
[No Abstract] [Full Text] [Related]
8. [Myelosarcoma as the primary manifestation of acute myeloid leukemia].
Kusenbach G; Rister M; Fohlmeister I; Brusis T
Klin Padiatr; 1986; 198(3):191-3. PubMed ID: 3459934
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic transplantation as therapy for acute myelogenous leukemia in the elderly.
Schiller GJ
Biol Blood Marrow Transplant; 2014 Apr; 20(4):437-8. PubMed ID: 24487045
[No Abstract] [Full Text] [Related]
10. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice.
Lee EM; Yee D; Busfield SJ; McManus JF; Cummings N; Vairo G; Wei A; Ramshaw HS; Powell JA; Lopez AF; Lewis ID; McCall MN; Lock RB
Haematologica; 2015 Jul; 100(7):914-26. PubMed ID: 26130514
[TBL] [Abstract][Full Text] [Related]
12. Progress in acute myelogenous leukemia: the one hundred years' war.
Lange B
J Pediatr Hematol Oncol; 1995 May; 17(2):91-3. PubMed ID: 7749771
[No Abstract] [Full Text] [Related]
13. Successful Unrelated Stem Cell Transplantation in an Infant With Congenital Acute Myelogenous Leukemia FAB M5 Showing Massive Cutaneous Infiltrations--A Challenging Multidisciplinary Approach.
Lanz S; Schwinger W; Sovinz P; Lackner H; Resch B; Urlesberger B; Sipurzynski S; Urban C
Pediatr Blood Cancer; 2016 Jan; 63(1):160-3. PubMed ID: 26291692
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic cell transplantation in high-risk childhood acute myelogenous leukemia.
Meshinchi S
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1002-3. PubMed ID: 23791357
[No Abstract] [Full Text] [Related]
15. Granulocytic sarcoma of the intestine as a primary manifestation nine months prior to overt acute myelogenous leukemia.
Toki H; Okabe K; Kimura Y; Kiura K; Shibata H; Hara K; Moriwaki S; Nanbu T; Iwashita A
Jpn J Clin Oncol; 1987 Mar; 17(1):79-85. PubMed ID: 3470535
[TBL] [Abstract][Full Text] [Related]
16. Isolated extramedullary relapse of acute myelogenous leukemia as a uterine granulocytic sarcoma in an allogeneic hematopoietic stem cell transplantation recipient.
Maeng H; Cheong JW; Lee ST; Yang WI; Hahn JS; Ko YW; Min YH
Yonsei Med J; 2004 Apr; 45(2):330-3. PubMed ID: 15119007
[TBL] [Abstract][Full Text] [Related]
17. Post-remission therapy in acute myeloid leukemia: what should I do now?
Blum W
Haematologica; 2008 Jun; 93(6):801-5. PubMed ID: 18515876
[No Abstract] [Full Text] [Related]
18. Langerhans' cell histiocytosis in an adult with acute myelogenous leukaemia.
Saiz A; Martinez MA; Grande C; Vanaclocha F
Virchows Arch; 2004 Jul; 445(1):93-5. PubMed ID: 15103559
[No Abstract] [Full Text] [Related]
19. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
Caron PC; Dumont L; Scheinberg DA
Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
[TBL] [Abstract][Full Text] [Related]
20. Advances in the treatment of acute myelogenous leukemia.
Gale RP
N Engl J Med; 1979 May; 300(21):1189-99. PubMed ID: 372809
[No Abstract] [Full Text] [Related]
[Next] [New Search]
